Pricing
Login
Home
Charts
Search
Watchlist
Products

Wanbury Ltd

WANBURY
₹179.37-1.26%20 Nov 2026
Reports
Pharma API

Wanbury Ltd

WANBURY
₹179.37
-1.26%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹627Cr
Close
Close Price
₹179.37
Industry
Industry
Pharma API
PE
Price To Earnings
11.13
PS
Price To Sales
0.93
Revenue
Revenue
₹676Cr
Rev Gr TTM
Revenue Growth TTM
7.45%
PAT Gr TTM
PAT Growth TTM
4.85%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
146139131161133172163160162165166183
Growth YoY
Revenue Growth YoY%
15.74.8-10.411.6-8.323.424.5-0.721.7-4.31.514.3
Expenses
ExpensesCr
124121120141120142139134136135149157
Operating Profit
Operating ProfitCr
211811201430242627301626
OPM
OPM%
14.513.08.412.410.417.215.016.116.418.19.814.3
Other Income
Other IncomeCr
111212000-300
Interest Expense
Interest ExpenseCr
87810109877886
Depreciation
DepreciationCr
333333444344
PBT
PBTCr
1081811914151615516
Tax
TaxCr
00000-1000-714
PAT
PATCr
1081812013151622312
Growth YoY
PAT Growth YoY%
413.1692.2-77.89.0-88.1150.71,197.189.31,191.87.1-76.0-21.7
NPM
NPM%
7.15.80.85.00.911.88.39.59.713.22.06.5
EPS
EPS₹
3.12.50.32.40.46.24.14.64.57.30.93.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
146139131161133172163160162165166183
Growth YoY
Revenue Growth YoY%
15.74.8-10.411.6-8.323.424.5-0.721.7-4.31.514.3
Expenses
ExpensesCr
124121120141120142139134136135149157
Operating Profit
Operating ProfitCr
211811201430242627301626
OPM
OPM%
14.513.08.412.410.417.215.016.116.418.19.814.3
Other Income
Other IncomeCr
111212000-300
Interest Expense
Interest ExpenseCr
87810109877886
Depreciation
DepreciationCr
333333444344
PBT
PBTCr
1081811914151615516
Tax
TaxCr
00000-1000-714
PAT
PATCr
1081812013151622312
Growth YoY
PAT Growth YoY%
413.1692.2-77.89.0-88.1150.71,197.189.31,191.87.1-76.0-21.7
NPM
NPM%
7.15.80.85.00.911.88.39.59.713.22.06.5
EPS
EPS₹
3.12.50.32.40.46.24.14.64.57.30.93.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
423434371391367393511500578600650676
Growth
Revenue Growth%
69.42.5-14.45.5-6.16.830.2-2.315.63.88.57.5
Expenses
ExpensesCr
391415439376344375476476506523544577
Operating Profit
Operating ProfitCr
3219-681623183523727610799
OPM
OPM%
7.74.3-18.34.06.44.66.94.612.512.816.414.6
Other Income
Other IncomeCr
19077984278013-3-3
Interest Expense
Interest ExpenseCr
323631403323212129373030
Depreciation
DepreciationCr
91010101010111213131415
PBT
PBTCr
-762-32-2565-1281-1031306051
Tax
TaxCr
000000000-1-6-1
PAT
PATCr
-762-32-2564-1381-1030316653
Growth
PAT Growth%
-319.3981.6-151.622.3359.4-119.6746.3-112.8392.40.4116.64.8
NPM
NPM%
-1.714.3-8.6-6.317.5-3.215.9-2.15.35.110.27.8
EPS
EPS₹
-3.529.8-13.5-10.526.9-5.025.3-3.29.39.320.416.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
423434371391367393511500578600650676
Growth
Revenue Growth%
69.42.5-14.45.5-6.16.830.2-2.315.63.88.57.5
Expenses
ExpensesCr
391415439376344375476476506523544577
Operating Profit
Operating ProfitCr
3219-681623183523727610799
OPM
OPM%
7.74.3-18.34.06.44.66.94.612.512.816.414.6
Other Income
Other IncomeCr
19077984278013-3-3
Interest Expense
Interest ExpenseCr
323631403323212129373030
Depreciation
DepreciationCr
91010101010111213131415
PBT
PBTCr
-762-32-2565-1281-1031306051
Tax
TaxCr
000000000-1-6-1
PAT
PATCr
-762-32-2564-1381-1030316653
Growth
PAT Growth%
-319.3981.6-151.622.3359.4-119.6746.3-112.8392.40.4116.64.8
NPM
NPM%
-1.714.3-8.6-6.317.5-3.215.9-2.15.35.110.27.8
EPS
EPS₹
-3.529.8-13.5-10.526.9-5.025.3-3.29.39.320.416.1
Sales CAGR
1 Year8%
3 Years9%
5 Years11%
TTM7%
EBITDA CAGR
1 Year40%
3 Years66%
5 Years43%
TTM5%
PAT CAGR
1 Year117%
3 Years-
5 Years-
TTM5%
Avg. ROCE
1 Year24%
3 Years32%
5 Years50%
TTM21%
CFO / EBITDA
1 Year30%
3 Years24%
5 Years39%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
202324242525333333333535
Reserves
ReservesCr
-195-151-183-207-143-156-30-40-1121110125
Current Liabilities
Current LiabilitiesCr
298375321334284328333293211175201207
Non Current Liabilities
Non Current LiabilitiesCr
251163109134111901616104180172207
Total Liabilities
Total LiabilitiesCr
386411271285277288351302343414518574
Current Assets
Current AssetsCr
16419073938896170120159193239275
Non Current Assets
Non Current AssetsCr
223220199192189192181182185221279299
Total Assets
Total AssetsCr
386411271285277288351302343414518574
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
202324242525333333333535
Reserves
ReservesCr
-195-151-183-207-143-156-30-40-1121110125
Current Liabilities
Current LiabilitiesCr
298375321334284328333293211175201207
Non Current Liabilities
Non Current LiabilitiesCr
251163109134111901616104180172207
Total Liabilities
Total LiabilitiesCr
386411271285277288351302343414518574
Current Assets
Current AssetsCr
16419073938896170120159193239275
Non Current Assets
Non Current AssetsCr
223220199192189192181182185221279299
Total Assets
Total AssetsCr
386411271285277288351302343414518574

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
434333304417412052632
Investing Cash Flow
Investing Cash FlowCr
-20-13-1-36481-9-17-51-56
Financing Cash Flow
Financing Cash FlowCr
-28-27-33-27-108-17-29-32142622
Net Cash Flow
Net Cash FlowCr
-53-200713-2121-2
Free Cash Flow
Free Cash FlowCr
434333304417512082731
CFO To PAT
CFO To PAT%
-613.570.0-101.6-119.668.5-132.349.7-190.415.485.847.7
CFO To EBITDA
CFO To EBITDA%
132.9234.2-47.9191.3188.292.6114.885.46.534.329.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
434333304417412052632
Investing Cash Flow
Investing Cash FlowCr
-20-13-1-36481-9-17-51-56
Financing Cash Flow
Financing Cash FlowCr
-28-27-33-27-108-17-29-32142622
Net Cash Flow
Net Cash FlowCr
-53-200713-2121-2
Free Cash Flow
Free Cash FlowCr
434333304417512082731
CFO To PAT
CFO To PAT%
-613.570.0-101.6-119.668.5-132.349.7-190.415.485.847.7
CFO To EBITDA
CFO To EBITDA%
132.9234.2-47.9191.3188.292.6114.885.46.534.329.5

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
92133745245208278122478769778627
Price To Earnings
Price To Earnings
2.10.73.415.725.211.811.1
Price To Sales
Price To Sales
0.20.30.20.10.10.50.50.20.81.31.20.9
Price To Book
Price To Book
-0.5-1.1-0.5-0.3-0.4-1.6149.1-16.521.814.45.43.9
EV To EBITDA
EV To EBITDA
12.518.4-3.716.46.520.19.28.18.212.29.38.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.146.946.544.444.336.835.333.041.144.851.251.2
OPM
OPM%
7.74.3-18.34.06.44.66.94.612.512.816.414.6
NPM
NPM%
-1.714.3-8.6-6.317.5-3.215.9-2.15.35.110.27.8
ROCE
ROCE%
17.0109.5-6.660.41,470.430.6134.218.243.528.924.321.1
ROE
ROE%
4.0-48.620.113.5-54.79.73,724.2143.2138.657.345.832.9
ROA
ROA%
-1.815.1-11.8-8.723.3-4.423.2-3.48.97.412.89.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
92133745245208278122478769778627
Price To Earnings
Price To Earnings
2.10.73.415.725.211.811.1
Price To Sales
Price To Sales
0.20.30.20.10.10.50.50.20.81.31.20.9
Price To Book
Price To Book
-0.5-1.1-0.5-0.3-0.4-1.6149.1-16.521.814.45.43.9
EV To EBITDA
EV To EBITDA
12.518.4-3.716.46.520.19.28.18.212.29.38.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.146.946.544.444.336.835.333.041.144.851.251.2
OPM
OPM%
7.74.3-18.34.06.44.66.94.612.512.816.414.6
NPM
NPM%
-1.714.3-8.6-6.317.5-3.215.9-2.15.35.110.27.8
ROCE
ROCE%
17.0109.5-6.660.41,470.430.6134.218.243.528.924.321.1
ROE
ROE%
4.0-48.620.113.5-54.79.73,724.2143.2138.657.345.832.9
ROA
ROA%
-1.815.1-11.8-8.723.3-4.423.2-3.48.97.412.89.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,3381,313795627515487257
Close PriceClose₹25.17446.1579.28179.3794.911,610.8058.67
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE30.7025.0216.6211.1331.7437.596.78
Price To SalesPS4.782.561.020.931.371.460.65
RevenueRevenueCr280513778676377334395
Revenue Growth TTMRev Gr TTM%-8.8%6.6%7.5%102.4%-1.0%
PAT Growth TTMPAT Gr TTM%-55.3%23.4%4.8%219.7%-44.7%
Market CapitalizationMkt CapCr1,3381,313795627515487257
Close PriceClose₹25.17446.1579.28179.3794.911,610.8058.67
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE30.7025.0216.6211.1331.7437.596.78
Price To SalesPS4.782.561.020.931.371.460.65
RevenueRevenueCr280513778676377334395
Revenue Growth TTMRev Gr TTM%-8.8%6.6%7.5%102.4%-1.0%
PAT Growth TTMPAT Gr TTM%-55.3%23.4%4.8%219.7%-44.7%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews